help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krett, N. L.
Right arrow Articles by Gelehrter, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krett, N. L.
Right arrow Articles by Gelehrter, T. D.

Endocrinology, Vol 120, 401-408, Copyright © 1987 by Endocrine Society


ARTICLES

Mediation of insulin-like growth factor actions by the insulin receptor in H-35 rat hepatoma cells

NL Krett, JH Heaton and TD Gelehrter

We have used H-35 rat hepatoma cells to test whether the type II insulin-like growth factor (IGF) receptor mediates metabolic responses to IGF-II. On the basis of both affinity cross-linking experiments and competition binding experiments, H-35 cells display insulin and type II IGF receptors, but not type I IGF receptors. IGF-II and multiplication- stimulating activity (MSA; the rat homolog of IGF-II) stimulate tyrosine aminotransferase, amino acid transport, and glycogen synthase activities to the same magnitude as insulin. However, MSA and IGF-II stimulate these metabolic responses only at high concentrations, indicating that these peptides are acting through the insulin receptor. Incubation of H-35 cells with MSA also induces a state of unresponsiveness to the further actions of both MSA and insulin. There is no associated loss of either insulin or IGF-II binding, indicating that desensitization occurs at a postbinding step in hormone action. The high concentration of MSA necessary to induce desensitization is also consistent with MSA acting through the insulin receptor. We conclude that in H-35 cells, the insulin receptor, rather than the type II IGF receptor, mediates the metabolic responses stimulated by MSA and IGF-II as well as the MSA-induced desensitization to insulin and MSA action.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Ji, R. Guan, S. J. Frank, and J. L. Messina
Insulin Inhibits Growth Hormone Signaling via the Growth Hormone Receptor/JAK2/STAT5B Pathway
J. Biol. Chem., May 7, 1999; 274(19): 13434 - 13442.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. P. Ceresa, A. W. Kao, S. R. Santeler, and J. E. Pessin
Inhibition of Clathrin-Mediated Endocytosis Selectively Attenuates Specific Insulin Receptor Signal Transduction Pathways
Mol. Cell. Biol., July 1, 1998; 18(7): 3862 - 3870.
[Abstract] [Full Text]


Home page
ScienceHome page
R. MacDonald, Pfeffer SR, L Coussens, M. Tepper, C. Brocklebank, J. Mole, J. Anderson, E Chen, M. Czech, and A Ullrich
A single receptor binds both insulin-like growth factor II and mannose-6-phosphate
Science, March 4, 1988; 239(4844): 1134 - 1137.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society